Andere Sprachen Telix Pharmaceuticals Limited

Aktien

A2H7JK

AU000000TLX2

TLX

Markt geschlossen - Australian S.E. Andere Börsenplätze 08:10:57 27.05.2024			% 5 Tage	% 1. Jan.
15,89 ^AUD	+2,71 %		+3,38 %	+57,64 %

01:21	Telix Pharmaceuticals Limited reicht NDA für neues Prostatakrebs-Imaging-Mittel ein	CI
21.05.	Telix Pharmaceuticals schließt Proof-of-Concept-Studie von fortgeschrittenem Prostatakrebs-Medikament ab	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Telix Pharmaceuticals Submits New Drug Application for Prostate Cancer Imaging Agent to US FDA	03:16
Telix Pharmaceuticals Limited Submits NDA for New Prostate Cancer Imaging Agent	01:21
Telix Pharmaceuticals Concludes Proof-of-Concept Study of Advanced Prostate Cancer Drug	21.05.
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer	21.05.
Telix Pharmaceuticals Files Registration Statement for Nasdaq IPO	20.05.
Telix Files Registration Statement for Proposed Initial Public Offering in the United States	17.05.
Telix Pharmaceuticals Limited has filed an IPO in the amount of $100 million.	17.05.
Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP	03.05.
Telix to Showcase Extensive Urologic Pipeline at AUA Annual Meeting including Phase III ProstACT GLOBAL Study of TLX591	01.05.
Telix - Notice of Annual General Meeting 2024	22.04.
Q1 2024 Revenue and Business Update	17.04.
Telix Pharmaceuticals Limited Reports Unaudited Revenue Results for the First Quarter Ended 31 March 2024	17.04.
Telix Pharmaceuticals Limited Reaffirms Revenue Guidance for the Year 2024	17.04.
Telix Pharmaceuticals Logs Nearly $115 Million Revenue in Q1	17.04.
Telix Pharmaceuticals Secures US FDA Fast-Track Designation for Brain Cancer Imaging Product	16.04.
TLX101-CDx (Pixclara™) Granted FDA Fast Track Designation	16.04.
Telix Pharmaceuticals Limited Announces FDA Fast Track Designation for TLX101-CDx	16.04.
Telix Pharmaceuticals Limited completa la adquisición de ARTMS Inc.	11.04.
Telix Pharmaceuticals Limited completes the acquisition of ARTMS, Inc.	11.04.
Telix Pharmaceuticals Completes Acquisition of Canadian Firm ARTMS	11.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Telix Pharmaceuticals Limited

Aktien

A2H7JK

AU000000TLX2

TLX

Andere Sprachen

Filter